Exploring the Relationship Between Radiation-Induced Moyamoya Syndrome and Radiation Dose for Pediatric Patients Treated With Proton Radiation Therapy

被引:0
|
作者
Gill, Gobind S. [1 ]
Baliga, Sujith [2 ]
Lewy, Jacqueline [3 ]
Bajaj, Benjamin V. [2 ]
Gallotto, Sara L. [2 ,3 ]
Fitzpatrick, Aibhlin [3 ]
Patteson, Brooke [4 ]
Speroni, Samantha [5 ]
Omsberg, Allison [3 ]
Caruso, Paul [6 ]
Rapalino, Otto [6 ]
Musolino, Patricia [5 ]
Yock, Torunn I.
机构
[1] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA
[2] Ohio State Univ, Dept Radiat Oncol, Columbus, OH USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA USA
[4] Childrens Healthcare Atlanta, Dept Pediat Hematol & Oncol, Atlanta, GA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat Neurol, Boston, MA USA
[6] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Boston, MA USA
关键词
PRIMARY BRAIN-TUMORS; CEREBRAL VASCULOPATHY; RISK-FACTORS; SURVIVORS; CANCER; STROKE; CHILDREN; DISEASE; CIRCLE;
D O I
10.1016/j.ijrobp.2024.11.070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The incidence and risk factors associated with radiation-induced moyamoya syndrome (RIMMS) in pediatric brain tumor patients treated with proton radiation therapy (PRT) remain poorly understood. The objective of this study was to determine the incidence of RIMMS in the setting of central nervous system PRT in a pediatric cohort and assess its relationship with dose to the circle of Willis (COW) or optic chiasm (OC). Methods and Materials: We performed a retrospective review of pediatric brain tumor patients treated with intracranial PRT (1995-2021). The exposure of interest was mean dose to the OC due to close proximity to the COW vasculature. Wilcoxon rank-sum test was used to determine the association between OC dose and RIMMS. Univariable logistic regression modeling was used to determine the odds of developing RIMMS based on a cut point of 52 Gy. Results: Of 676 patients, 14 developed RIMMS, with a median onset of 1.9 years. The cumulative incidence of RIMMS at 8 years was 2.4%. Patients with RIMMS had a higher mean OC dose than those without (51.5 vs 23.7 Gy, P < .0001). Univariable logistic regression showed that patients with an OC dose > 52 Gy had increased RIMMS risk compared with those with a dose < 52 Gy (odds ratio = 9.9, P < .001). Conclusions: The incidence of RIMMS remains low in our primarily proton-treated pediatric cohort with a cumulative incidence of 2.4% over 8 years and is similar to that of photon-treated cohorts. Development of RIMMS was associated with higher doses to the COW and OC. (c) 2024 Published by Elsevier Inc.
引用
收藏
页码:1209 / 1218
页数:10
相关论文
共 50 条
  • [31] Magnetic resonance imaging detected radiation-induced changes in patients with proton radiation-treated arteriovenous malformations
    de Verdier, Maria Correia
    Ronne-Engstrom, Elisabeth
    Borota, Ljubisa
    Nilsson, Kristina
    Blomquist, Erik
    Wikstrom, Johan
    ACTA RADIOLOGICA OPEN, 2021, 10 (10)
  • [32] Radiation-induced lymphopenia in proton therapy for prostate cancer
    Al-Hamami, Sarah F. A.
    Kurucz, Samuel
    Vondracek, Vladimir
    Pekar, Vladimir
    Kubes, Jiri
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5160 - S5162
  • [33] Defining the Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated With Stereotactic Body Radiation Therapy
    Choi, H. S.
    Song, J. H.
    Jeong, B. K.
    Jeong, H. J.
    Lee, Y. H.
    Jung, J. H.
    Woo, S. H.
    Kim, J. H.
    Kang, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E188 - E188
  • [34] Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy
    Ellsworth, Susannah G.
    Yalamanchali, Anirudh
    Zhang, Hong
    Grossman, Stuart A.
    Hobbs, Robert
    Jin, Jian-Yue
    RADIATION RESEARCH, 2020, 193 (01) : 73 - 81
  • [35] Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study
    Daguenet, E.
    Maison, M.
    Tinquaut, F.
    Giroux, E. -A.
    Bertoletti, L.
    Suchaud, J. -P.
    Rancoule, C.
    Guy, J. -B.
    Magne, N.
    THROMBOSIS RESEARCH, 2022, 213 : S21 - S21
  • [36] Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy
    Colen, Jonathan
    Nguyen, Cam
    Liyanage, Seth W.
    Aliotta, Eric
    Chen, Joe
    Alonso, Clayton
    Romano, Kara
    Peach, Sean
    Showalter, Timothy
    Read, Paul
    Larner, James
    Wijesooriya, Krishni
    MEDICAL PHYSICS, 2024, 51 (09) : 6485 - 6500
  • [37] Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy
    Diot, Quentin
    Kavanagh, Brian
    Vinogradskiy, Yevgeniy
    Garg, Kavita
    Gaspar, Laurie
    Miften, Moyed
    MEDICAL PHYSICS, 2015, 42 (11) : 6477 - 6487
  • [38] Predictive factors of severe radiation-induced lymphopenia in proton-treated patients
    Pan, S.
    Sitch, P.
    Gaito, S.
    McPartlin, A.
    Sashidaran, S.
    Smith, E.
    Whitfield, G.
    Abravan, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S51 - S53
  • [39] IMAGING CHANGES IN PEDIATRIC EPENDYMOMA PATIENTS TREATED WITH PROTON BEAM RADIATION THERAPY
    Bouzid, Nadia
    Goudgil, Farid
    Bolle, Stephanie
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S509 - S509
  • [40] Radiation-induced instability and its relationship to radiation carcinogenesis
    Ullrich, RL
    RADIATION RESEARCH, VOL 2, CONGRESS PROCEEDINGS, 2000, : 508 - 509